17 окт 2014 г. - FDA approved new labeling for Embeda (morphine sulfate and naltrexone hydrochloride), an extended-release (ER) opioid analgesic to treat pain severe enough to require daily, around-the- clock, long-term opioid treatment and for which alternative treatment options are inadequate.
Добавлено на ленту времени:
Дата:
17 окт 2014 г.
Сейчас
~ 11 г назад